Target intelligence / Profile preview

Lipid II peptidoglycan precursor (Lipid II)

Target
Lipid II
Molecular classification
Other (membrane-anchored precursor), Peptidoglycan biosynthesis intermediate, Not an enzyme, receptor, or transporter, but the essential substrate for cell wall biogenesis, Lipid-linked glycopeptide precursor
01

Overview

Lipid II is the universally conserved membrane-bound precursor for bacterial peptidoglycan biosynthesis. Its structure consists of a hydrophobic undecaprenyl lipid tail linked by pyrophosphate to a disaccharide unit of N-acetylglucosamine and N-acetylmuramic acid, which carries a pentapeptide stem. Synthesized on the inner leaflet of the bacterial cytoplasmic membrane, Lipid II is translocated (“flipped”) across the membrane by the MurJ flippase (or, controversially, FtsW), exposing its moiety for polymerization and cross-linking into peptidoglycan. It is essential for bacterial growth, division, and maintenance of cell shape. Numerous classes of antibiotics—including vancomycin, teicoplanin, ramoplanin, nisin, and plectasin—kill bacteria by binding to and sequestering Lipid II, thereby blocking cell wall synthesis. Because Lipid II and the enzymes and transporters associated with its metabolism are unique to bacteria, targeting these molecules avoids toxicity to mammalian cells and has become a major strategy for the development of antimicrobial agents.

Other names
Lipid IIUndecaprenyl pyrophosphoryl disaccharide-pentapeptidePeptidoglycan precursor lipid IIBacterial cell wall lipid IIShuttle carrier of peptidoglycan building blocks
02

Mechanism of action

Inhibition of cell wall biosynthesis by sequestering lipid II (vancomycin, teicoplanin, ramoplanin, nisin, plectasin); Interference with the translocation of lipid II across the membrane (various antibiotics inhibit flippases/MurJ); Blockage of peptidoglycan polymerization and crosslinking

03

Biological functions

Bacterial cell wall biogenesisShuttle for peptidoglycan monomers across the cytoplasmic membraneEssential for cell division and shape maintenancePili assembly in gram-positive bacteria
04

Disease associations

Infection (target for antibiotics against bacterial infections)Other (relevant for antibacterial resistance mechanisms and targeting)
05

Safety considerations

No notable safety concerns associated with targeting lipid II itself in bacteria—it is absent from eukaryotic cells, making it an attractive, selective antibacterial targetTherapeutic challenges: development of drug resistance through modification of lipid II structureDrug penetration and delivery to the bacterial cell envelope, particularly in Gram-negative bacteria where the outer membrane poses a barrier
06

Interacting drugs

Vancomycin

6 more in the full profile.

07

Biomarkers

Lipid II accumulation or depletion in bacterial cells may indicate effective antibiotic mechanism or bacterial susceptibilityNot used directly as a biomarker in patients, but detection in bacterial cultures is pivotal in drug mechanism studies

Beyond the preview

Go deeper on Lipid II peptidoglycan precursor (Lipid II).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid II peptidoglycan precursor (Lipid II).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call